Classification of Parkinsonism
in Handbook of Parkinson's Disease, Marcel Dekker, Inc, New York, Ch 3, p 61., Koller,W.C., 1987
Exacerbation of Parkinsonism by Methyldopa
JAMA 244:2727-2728, Rosenblum,A.M.&Montgomery,E.B., 1980
Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972
Methyldopahydrazine as an Adjunct to L-Dopa Therapy in Parkinsonism
Neurol 22:384, Chase,T.,et al, 1972
Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1972 Sept., , 1972
Parkinsons Disease
NEJM 391:442-452, Tanner,C.M. & Ostrem,J.L., 2024
Cutaneous a-Synuclein Signatures in Patients with MultipleSystem Atrophy and Parkinson Disease
Neurol 100:e1529-e1539, Gibbons,C.,et al, 2023
Skin Nerve (-Synuclein Deposits
Neurol 82:1362-1369, Donadio, V.,et al, 2014
Incidence and Pathology of Synucleinopathies and Tauopathies Related to Parkinsonism
JAMA Neurol 70:859-866, Savica, R.,et al, 2013
(-Synuclein Accumulation in Skin Nerve Fibers Revealed by Skin Biopsy in Pure Autonomic Failure
Neurol 74:608-610,536, Shishido,T.,et al, 2010
Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009
a-Synuclein Gene Duplication Is Present in Sporadic Parkinson Disease
Neurol 70:43-49,7, Ahn,T.-B.,et al, 2008
Invited Article: Changing Concepts in Parkinson Disease: Moving Beyond the Decade of the Brain
Neurol 70:1996-2003, Marras,C. &Lang,A., 2008
The Parkinsons Complex: Parkinsonism Is Just the Tip of the Iceberg
Ann Neurol 59:591-596, Langston,J.W., 2006
Collaborative Analysis of a-Synuclein Gene Promotor Variability and Parkinson Disease
JAMA 296:661-670, Maraganore,D.M.,et al, 2006
Staging of Brain Pathology Related to Sporadic Parkinsons Disease
Neurobiol Aging 24:197-211, Braak,H.,et al, 2003
Distinction of Idiopathic Parkinson's Dis from Multi-Syst Atrophy by Stim of Growth-Hormone Release w Clonidine
Lancet 349:1877-1881, Kimber,J.R.,et al, 1997
Function of the Basal Ganglia
Handbook of Clinical Neurology 6:90-115, Ward,A., 1968